Pan-European care giant Korian has bought the third largest mental health platform in Spain following its re-entry to the mental health sector with its purchase of French group Inicea.
Bupa is replacing its ‘Global and UK’ market unit CEO David Hyman in one of the first senior changes under new group CEO Iñaki Ereño. Full-year results show flat revenue and a 4% drop in underlying profits.
We talk to Dr Abarca Cidon, part of the controlling family and current president of Spain's third-largest for-profit hospital group HM Hospitales with nearly €500m in sales. He talks strategy, Covid, and rumours of selling a stake in the company.
Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.
The former CEO of lab group Unilabs' teleradiology arm TMC, Alexander Böhmcker, has joined the eighth most-funded imaging AI company in the world, Aidoc, as VP Europe. We talk to Böhmcker. What does the move say about the two sectors which had very different 2020s?
Spain-listed diagnostics and radiotherapy group Atrys Health's CFO talks HBI through the strategic rationale of its spate of recent acquisitions including a €550m merger with another listed group, after we questioned the diversity of deal-making it is pursuing. He says it is looking at acquiring radiotherapy centres in Europe outside Iberia.
Spanish listed precision medicine, diagnostics and radiotherapy group Atrys Health continued its relentless M&A drive through 2020 and has started 2021 with its biggest deal yet. But how much is too much?
Pan-European imaging operator Affidea and Andalusia-based group HT Medica have resumed their consolidation of Spain's imaging market with single-centre deals in January. Meanwhile, France's third-largest consolidator has grown to 300 radiologists with private equity backing.
Imaging AI solutions which can read images just as well as radiologists are now demonstrably effective medical products that will revolutionise the medical imaging industry forever. $1.5bn in VC funding has been ploughed into companies developing solutions whose tech promises to transform diagnosis and improve operational efficiency. We talk to seven of them who've commercialised products in 2019/20, operators using them, and look at the sector in detail in this long-read feature.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
